08.08.17
Oscar Sanchez has been appointed vice president of quality, AMAG Pharmaceuticals. He reports to Joseph Vittiglio, general counsel and senior vice president of legal affairs and quality.
Mr. Sanchez is responsible for creating and implementing programs, policies and procedures related to quality assurance and quality control activities across the company’s commercially-available therapeutics, multiple development stage products and cord blood banking services. He will also provide compliance oversight of activities involving recognized quality standards, such as good manufacturing practices and good clinical practices, as well as accreditations and industry certifications.
“Oscar brings a wealth of experience to AMAG, having led the quality function at various global pharmaceutical organizations,” said Mr. Vittiglio. “His quality and regulatory experience will be essential to our business as AMAG continues to develop and market novel therapeutics to address significant unmet medical needs.”
Mr. Sanchez has more than 25 years of experience in the pharmaceutical and medical device industries, serving in leadership roles at organizations such as Albany Molecular Research Institute, MAQUET, Novartis and General Electric Healthcare, among others.
Mr. Sanchez is responsible for creating and implementing programs, policies and procedures related to quality assurance and quality control activities across the company’s commercially-available therapeutics, multiple development stage products and cord blood banking services. He will also provide compliance oversight of activities involving recognized quality standards, such as good manufacturing practices and good clinical practices, as well as accreditations and industry certifications.
“Oscar brings a wealth of experience to AMAG, having led the quality function at various global pharmaceutical organizations,” said Mr. Vittiglio. “His quality and regulatory experience will be essential to our business as AMAG continues to develop and market novel therapeutics to address significant unmet medical needs.”
Mr. Sanchez has more than 25 years of experience in the pharmaceutical and medical device industries, serving in leadership roles at organizations such as Albany Molecular Research Institute, MAQUET, Novartis and General Electric Healthcare, among others.